Assuming 700 is required, the following results were found.

  • NARCRMS ENROLLMENT MILESTONE: 700 MULTIPLE SCLEROSIS PARTICIPANTS ENROLLED

    NJ, March 2020) — The North American Registry for Care and Research in MS (NARCRMS) is pleased to announce enrollment of its 700th patient on Wednesday, February 26, 2020. NARCRMS anticipates enrolling up to 1,250 patients across 30 sites in the US and...

    https://mschristian.org/index.php/articles/2-uncategorised/10597-narcrms-enrollment-milestone-700-multiple-sclerosis-participants-enrolled
  • MS Patients Have Low Blood Levels of Infection-fighting Antibodies, Study Finds - Multiple Sclerosis News Today

    Hospital group (Greece) — totaling 327 patients. They found that 15.3% of the MS patients had lower-than-normal (less than 700 mg/dL) levels of a type of antibody called immunoglobulin G (IgG), the most common type of antibody the body produces. These...

    https://mschristian.org/index.php/articles/2-uncategorised/9076-ms-patients-have-low-blood-levels-of-infection-fighting-antibodies-study-finds-multiple-sclerosis-news-today
  • MS Patients Have Low Blood Levels of Infection-fighting Antibodies, Study Finds - Multiple Sclerosis News Today

    Hospital group (Greece) — totaling 327 patients. They found that 15.3% of the MS patients had lower-than-normal (less than 700 mg/dL) levels of a type of antibody called immunoglobulin G (IgG), the most common type of antibody the body produces. These...

    https://mschristian.org/index.php/blog/ms-patients-have-low-blood-levels-of-infection-fighting-antibodies-study-finds-multiple-sclerosis-news-today
  • NARCRMS ENROLLMENT MILESTONE: 700 MULTIPLE SCLEROSIS PARTICIPANTS ENROLLED

    NJ, March 2020) — The North American Registry for Care and Research in MS (NARCRMS) is pleased to announce enrollment of its 700th patient on Wednesday, February 26, 2020. NARCRMS anticipates enrolling up to 1,250 patients across 30 sites in the US and...

    https://mschristian.org/index.php/blog/narcrms-enrollment-milestone-700-multiple-sclerosis-participants-enrolled
  • Short-Duration Opioid Protocol Feasible for Tonsillectomy

    dependence within the first year after surgery, a retrospective analysis of active-duty military personnel showed. Of almost 700 patients who received as much as a 15-day postoperative prescription of opioid-containing medication, none had a referral...

    https://mschristian.org/index.php/blog/short-duration-opioid-protocol-feasible-for-tonsillectomy
  • With Bristol-Myers CVR, Investors Can Bet on 3 Drugs in Celgene’s Pipeline - Barron's

    to a Sanofi press release announcing the settlement. In the case of Bristol-Myers and Celgene, there will be more than 700 million of the CVRs outstanding. Trading is expected to be active, especially in the initial days following issuance amid expected...

    https://mschristian.org/index.php/articles/2-uncategorised/9321-with-bristol-myers-cvr-investors-can-bet-on-3-drugs-in-celgene-s-pipeline-barron-s
  • Short-Duration Opioid Protocol Feasible for Tonsillectomy

    dependence within the first year after surgery, a retrospective analysis of active-duty military personnel showed. Of almost 700 patients who received as much as a 15-day postoperative prescription of opioid-containing medication, none had a referral...

    https://mschristian.org/index.php/articles/2-uncategorised/8654-short-duration-opioid-protocol-feasible-for-tonsillectomy
  • With Bristol-Myers CVR, Investors Can Bet on 3 Drugs in Celgene’s Pipeline - Barron's

    to a Sanofi press release announcing the settlement. In the case of Bristol-Myers and Celgene, there will be more than 700 million of the CVRs outstanding. Trading is expected to be active, especially in the initial days following issuance amid expected...

    https://mschristian.org/index.php/blog/with-bristol-myers-cvr-investors-can-bet-on-3-drugs-in-celgene-s-pipeline-barron-s

Results 1 - 8 of 8